Investing
The company eyes overseas expansion and wants to offer more telemental health services.
It plans to secure more regulatory approvals for its AI pathology platform.
The funds will help expand the company's deployment of its in-home kidney and polychronic care delivery model and its clinical services.
The investment will help expand the telepsychiatry platform's reach.
Cancer care platform Onc.AI, data analytics company Porter and virtual care platform KeyCare also closed funding rounds.
The startup, which also announced a $3.4 million raise, aims to collect longitudinal patient data for research.
PharmStars founder and CEO Naomi Fried talks about the company's call for applications to digital health companies that aim to improve women's health and health equity for underserved populations.
Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.
Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.